חוב לטווח קצר להון: Tenax Therapeutics (TENX)

Tenax Therapeutics (TENX) is developing unique treatments for pulmonary hypertension, aiming to outperform industry behemoths during final testing. This daily price action reflects the process, with the indicator standing at 0.00. The production cycle relies on third-party bio-factories and laboratories in North Carolina. Environmental policy mandates that the business implement energy-efficient logistics and the disposal of hazardous chemicals.

Tenax Therapeutics (TENX) utilizes AI platforms to accelerate the development of cardiology drugs, which necessitates flexible liquidity management. This indicator measures the share of short-term liabilities (up to one year) within the equity structure, reflecting the company's degree of reliance on short-term borrowings to finance operating cycles, a trend clearly captured by the history of short-term debt to equity.